Overview
Laura Palomo practices in Barcelona, Spain. Ms. Palomo is rated as an Elite expert by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). Her top areas of expertise are Chronic Myelomonocytic Leukemia (CMML), Myelodysplastic Syndrome (MDS), Leukemia, and Acute Myeloid Leukemia (AML).
Her clinical research consists of co-authoring 45 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles in the study of Chronic Myelomonocytic Leukemia (CMML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Myelomonocytic Leukemia (CMML)
- Distinguished
- Myelodysplastic Syndrome (MDS)Ms. Palomo isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- LeukemiaMs. Palomo isAdvanced. Learn about Leukemia.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Palomo isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaMs. Palomo isExperienced. Learn about Anemia.
- B-Cell LymphomaMs. Palomo isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Ms. Palomo isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Palomo isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Ms. Palomo isExperienced. Learn about Chronic Myelogenous Leukemia (CML).